News
Global Antibody Discovery Market To Observe Stupendous Growth At A CAGR Of ~10% By 2032 Delveinsight
The antibody discovery market is expanding, driven by the increasing incidence of chronic conditions such as cancer, diabetes, and cardiovascular and ...
(Reuters) -British drugmaker GSK expects annual sales and profit to be towards the top of its forecast range, after ...
BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...
Pfizer (PFE) is currently under significant scrutiny due to a study linking its product, Depo-Provera, to increased health risks, and an associated Multi-District Litigation could have influenced its ...
The rising occurrence of dysmenorrhea, along with greater awareness and advancements in diagnosis, is driving substantial growth in the dysmenorrhea ...
The Canadian Patent Office has a procedure for the “re-examination” of a granted patent. However, this procedure is rarely used in Canada for several reasons. Less than half a dozen re-examinations ...
22d
Zacks Investment Research on MSNJNJ vs. Pfizer: Which Pharma Giant is the Better Investment Now?
Johnson & Johnson JNJ and Pfizer PFE rank among the world’s largest pharmaceutical companies, each with broad and diversified healthcare portfolios. J&J operates primarily through its pharmaceuticals ...
Key considerations for discovery in AI-focused intellectual property (IP) litigation, including an examination of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results